• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chemomab Therapeutics Ltd ADR (NQ: CMMB )

    0.6800 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.6800
    Bid (Size) 0.6405 (12)
    Ask (Size) 0.7500 (3)
    Prev. Close 0.6800
    Today's Range 0.6800 - 0.6800
    52wk Range 0.4200 - 1.770
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
    From Chemomab Therapeutics
    Via GlobeNewswire
    Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
    From Chemomab Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    +26.44%
    +26.44%
    1 Month
    -11.83%
    -11.83%
    3 Month
    +25.93%
    +25.93%
    6 Month
    -8.11%
    -8.11%
    1 Year
    -54.51%
    -54.51%

    More News

    Read More
    Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
    From Chemomab Therapeutics
    Via GlobeNewswire
    Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
    From Chemomab Therapeutics
    Via GlobeNewswire
    CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    US Stocks Gain; Producer Prices Fall In October
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why is Liver Disease Focused Chemomab Stock Trading Higher Today?
    Via Benzinga
    Exposures Product Safety
    Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    What's Going On With Chemomab Therapeutics Stock Today
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
    Via Benzinga
    Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.